Exploratory analysis comparing different dose regimens.
- Rebecca M. Turner (229235)
- Myfanwy Lloyd-Jones (333839)
- Dilly O. C. Anumba (333841)
- Gordon C. S. Smith (146512)
- David J. Spiegelhalter (178758)
- Hazel Squires (333843)
- John W. Stevens (333844)
- Michael J. Sweeting (333845)
- Stanislaw J. Urbaniak (333846)
- Robert Webster (333847)
- Simon G. Thompson (227951)
Publication date
February 2013
DOIAbstract
<p>For each of seven RAADP treatment regimens: elicited relative effectiveness compared to an optimally effective treatment (67% intervals pooled across assessors); observed odds ratios comparing RAADP to control (with 95% intervals), where available; and odds ratios expected in a future study comparing RAADP to control (with 95% intervals), obtained from a fitted meta-regression model. (Higher values for relative effectiveness compared to an optimal treatment correspond to lower odds ratios compared to control.).</p
Add to ORKG